NCT03465241View on ClinicalTrials.gov

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS

CompletedOBSERVATIONAL
Enrollment

119

Participants

Timeline

Start Date

October 21, 2017

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions
NSCLC
Interventions
DIAGNOSTIC_TEST

the ctDNA dynamic monitoring

To detect ctDNA in patients using the second generation of high-throughput gene sequencing (NGS)

Trial Locations (1)

Unknown

Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT03465241 - ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS | Biotech Hunter | Biotech Hunter